华熙生物所属申万行业为：美容护理-医疗美容-医美耗材。所属概念板块包括：化妆品、生物制造、医 疗器械、基金重仓、增持回购等。 截至11月20日，华熙生物股东户数3.01万，较上期减少0.62%；人均流通股16014股，较上期增加 0.62%。2025年1月-9月，华熙生物实现营业收入31.63亿元，同比减少18.36%；归母净利润2.52亿元，同 比减少30.29%。 分红方面，华熙生物A股上市后累计派现11.38亿元。近三年，累计派现5.28亿元。 机构持仓方面，截止2025年9月30日，华熙生物十大流通股东中，易方达上证科创板50ETF（588080） 位居第三大流通股东，持股696.42万股，相比上期减少101.36万股。华夏上证科创板50成份ETF （588000）位居第四大流通股东，持股681.95万股，相比上期减少382.34万股。华宝中证医疗ETF （512170）位居第七大流通股东，持股537.40万股，相比上期减少105.90万股。南方中证500ETF （510500）位居第八大流通股东，持股287.49万股，相比上期减少4.80万股。香港中央结算有限公司位 居第九大流通股东，持股267.6 ...

11月25日，水羊股份盘中上涨2.09%，截至13:53，报19.50元/股，成交1.74亿元，换手率2.50%，总市值 76.05亿元。 资金流向方面，主力资金净流出34.60万元，特大单买入0.00元，占比0.00%，卖出104.86万元，占比 0.60%；大单买入3794.16万元，占比21.86%，卖出3723.90万元，占比21.45%。 水羊股份今年以来股价涨47.50%，近5个交易日跌9.89%，近20日跌11.84%，近60日跌9.60%。 今年以来水羊股份已经1次登上龙虎榜，最近一次登上龙虎榜为5月28日，当日龙虎榜净买入2448.89万 元；买入总计2.08亿元 ，占总成交额比20.90%；卖出总计1.84亿元 ，占总成交额比18.44%。 截至11月10日，水羊股份股东户数3.00万，较上期增加10.64%；人均流通股11966股，较上期减少 9.61%。2025年1月-9月，水羊股份实现营业收入34.09亿元，同比增长11.96%；归母净利润1.36亿元，同 比增长44.01%。 分红方面，水羊股份A股上市后累计派现1.42亿元。近三年，累计派现7781.42万元。 机构持仓方面，截止 ...

Core Viewpoint - Marubi Biotechnology's stock has shown fluctuations in recent trading, with a current price of 33.64 CNY per share and a market capitalization of 13.49 billion CNY, reflecting a year-to-date increase of 6.76% [1] Financial Performance - For the period from January to September 2025, Marubi Biotechnology achieved a revenue of 2.45 billion CNY, representing a year-on-year growth of 25.51%, while the net profit attributable to shareholders was 244 million CNY, up 2.13% year-on-year [2] - Cumulative cash dividends since the company's A-share listing amount to 1.08 billion CNY, with 710 million CNY distributed over the past three years [3] Stock Market Activity - As of November 25, 2023, Marubi's stock price increased by 2.25% during the trading session, with a trading volume of approximately 79.75 million CNY and a turnover rate of 0.60% [1] - The stock has appeared on the "Dragon and Tiger List" once this year, with the most recent occurrence on August 25, 2023, where it recorded a net buy of -779.08 million CNY [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased by 8.86% to 18,900, with an average of 21,205 circulating shares per shareholder, a decrease of 8.14% [2] - Among the top ten circulating shareholders, several funds maintained their holdings, while Hong Kong Central Clearing Limited exited the list [3]

11月24日，华熙生物盘中上涨2.03%，截至13:15，报49.86元/股，成交6169.62万元，换手率0.26%，总 市值240.16亿元。 资金流向方面，主力资金净流出106.80万元，大单买入810.65万元，占比13.14%，卖出917.46万元，占 比14.87%。 截至10月31日，华熙生物股东户数3.06万，较上期增加0.86%；人均流通股15749股，较上期减少 0.85%。2025年1月-9月，华熙生物实现营业收入31.63亿元，同比减少18.36%；归母净利润2.52亿元，同 比减少30.29%。 分红方面，华熙生物A股上市后累计派现11.38亿元。近三年，累计派现5.28亿元。 机构持仓方面，截止2025年9月30日，华熙生物十大流通股东中，易方达上证科创板50ETF（588080） 位居第三大流通股东，持股696.42万股，相比上期减少101.36万股。华夏上证科创板50成份ETF （588000）位居第四大流通股东，持股681.95万股，相比上期减少382.34万股。华宝中证医疗ETF （512170）位居第七大流通股东，持股537.40万股，相比上期减少105.90万股。南方中 ...

嘉必优所属申万行业为：基础化工-化学制品-食品及饲料添加剂。所属概念板块包括：宠物经济、合成 生物、化妆品、多胎概念、湖北自贸区等。 截至9月30日，嘉必优股东户数8362.00，较上期增加1.01%；人均流通股20127股，较上期减少1.00%。 2025年1月-9月，嘉必优实现营业收入4.28亿元，同比增长10.56%；归母净利润1.29亿元，同比增长 54.18%。 分红方面，嘉必优A股上市后累计派现2.43亿元。近三年，累计派现1.03亿元。 11月21日，嘉必优盘中下跌2.04%，截至10:09，报23.04元/股，成交2331.54万元，换手率0.60%，总市 值38.78亿元。 资金流向方面，主力资金净流入25.49万元，特大单买入0.00元，占比0.00%，卖出100.50万元，占比 4.31%；大单买入571.01万元，占比24.49%，卖出445.02万元，占比19.09%。 嘉必优今年以来股价涨22.36%，近5个交易日跌7.36%，近20日跌4.20%，近60日跌17.63%。 今年以来嘉必优已经1次登上龙虎榜，最近一次登上龙虎榜为3月14日，当日龙虎榜净买入1850.19万 元；买入 ...

Core Viewpoint - The stock of Furuida has experienced a decline, with a current price of 7.75 yuan per share and a market capitalization of 7.878 billion yuan, reflecting a challenging financial performance in recent periods [1][2]. Company Performance - Furuida's stock price has increased by 3.33% year-to-date, but it has seen a decline of 3.00% over the last five trading days, 1.77% over the last 20 days, and 9.57% over the last 60 days [1]. - For the period from January to September 2025, Furuida reported a revenue of 2.597 billion yuan, a year-on-year decrease of 7.34%, and a net profit attributable to shareholders of 142 million yuan, down 17.19% year-on-year [2]. Shareholder and Market Activity - As of September 30, 2025, Furuida had 44,500 shareholders, a decrease of 6.27% from the previous period, with an average of 22,827 circulating shares per shareholder, an increase of 6.69% [2]. - The company has made cumulative cash distributions of 1.196 billion yuan since its A-share listing, with 213 million yuan distributed over the last three years [3]. Institutional Holdings - Among the top ten circulating shareholders, the Southern CSI 1000 ETF holds 4.6498 million shares, having decreased its holdings by 70,900 shares compared to the previous period [3].

11月20日，上海家化盘中下跌2.00%，截至10:50，报23.52元/股，成交5148.89万元，换手率0.32%，总 市值158.11亿元。 责任编辑：小浪快报 今年以来上海家化已经1次登上龙虎榜，最近一次登上龙虎榜为10月28日，当日龙虎榜净买入-1.80亿 元；买入总计1.77亿元 ，占总成交额比23.40%；卖出总计3.57亿元 ，占总成交额比47.15%。 资料显示，上海家化联合股份有限公司位于上海市虹口区东长治路399号双狮汇大厦A座11F，成立日期 1995年12月1日，上市日期2001年3月15日，公司主营业务涉及护肤、个护家清、母婴产品的研发、生产 和销售。主营业务收入构成为：个护45.70%，美妆21.48%，海外20.20%，创新12.55%，其他0.04%，租 赁0.02%，销售材料0.02%。 上海家化所属申万行业为：美容护理-化妆品-品牌化妆品。所属概念板块包括：化妆品、MSCI中国、 多胎概念、融资融券、中盘等。 截至9月30日，上海家化股东户数2.96万，较上期减少21.58%；人均流通股22704股，较上期增加 27.52%。2025年1月-9月，上海家化实现营业收入49 ...

11月20日，贝泰妮盘中下跌2.02%，截至10:27，报42.74元/股，成交1.24亿元，换手率0.68%，总市值 181.05亿元。 资金流向方面，主力资金净流出1591.54万元，特大单买入1197.98万元，占比9.69%，卖出1888.49万 元，占比15.27%；大单买入2612.40万元，占比21.12%，卖出3513.43万元，占比28.41%。 贝泰妮今年以来股价涨1.54%，近5个交易日跌1.16%，近20日跌6.31%，近60日跌8.30%。 贝泰妮所属申万行业为：美容护理-化妆品-品牌化妆品。所属概念板块包括：化妆品、人工智能、出海 概念、医疗器械、融资融券等。 截至11月10日，贝泰妮股东户数3.97万，较上期增加3.94%；人均流通股10681股，较上期减少3.79%。 2025年1月-9月，贝泰妮实现营业收入34.64亿元，同比减少13.78%；归母净利润2.72亿元，同比减少 34.45%。 分红方面，贝泰妮A股上市后累计派现12.89亿元。近三年，累计派现8.44亿元。 机构持仓方面，截止2025年9月30日，贝泰妮十大流通股东中，香港中央结算有限公司位居第六大流通 股东， ...

Market Overview - The three major US stock indices hit a one-month low, with the S&P 500 down 0.92%, the Dow Jones down 1.18%, and the Nasdaq down 0.84% [1] - Financial and energy sectors fell nearly 2%, leading the decline in the S&P; the chip index dropped over 1% for three consecutive days, with Nvidia retreating nearly 2% [1] - The Chinese concept stock index fell over 1% for five consecutive days, with Xiaopeng Motors' stock dropping 10% after its earnings report [1] - US Treasury prices saw a decrease in decline, with the 10-year Treasury yield retreating after two days of increases [1] Currency and Commodities - The US dollar index continued to rise from a four-week low, while the offshore RMB fell over 100 points, breaching the 7.11 mark [2] - Oil prices retreated after two days of gains, and gold prices fell for three consecutive days to a one-week low, with spot gold dropping over 2% [2] Domestic Major Events - High-level financial dialogue between China and Germany held in Beijing, achieving multiple consensus outcomes and easing trade tensions [3] - The Hydrogen Energy Branch of the China Industrial Development Promotion Association held a seminar, releasing the "Initiative for Healthy Development of China's Electrolyzer Industry" [3] - The Ministry of Commerce and six other departments issued a notice to promote the "East Silk West Solid" initiative in the silk industry, encouraging the creation of regional public brands [3] - The National Medical Products Administration released opinions on deepening cosmetic regulation reforms to promote high-quality industry development [3] - The National Development and Reform Commission, along with the Ministry of Finance, issued opinions on accelerating the construction of modern state-owned forest farms [3] - The 2025 Quantum Technology and Industry Conference will be held from November 20 to 22, showcasing significant technological and industrial achievements [3] Industry Insights - Semiconductor: SMIC reported a 95.8% capacity utilization rate in Q3, indicating high demand, but the lack of significant growth in Q4 guidance is attributed to high memory prices causing customer hesitance [8] - Shipping: European shipping futures surged by 6.73%, with Maersk planning to raise freight rates for routes from Far East to Northern Europe starting December 1 [9] - 3D Printing: A significant breakthrough was achieved with the successful flight test of a 3D-printed simplified turbojet engine, marking a transition from technology validation to large-scale application [10] - Cosmetics: The National Medical Products Administration's new policies aim to foster a supportive environment for innovation and promote the emergence of competitive domestic brands [11] Company Announcements - New IPO: Jingchuang Electric plans to issue shares at 12.10 yuan each, focusing on cold chain intelligent control products, holding the largest market share in China [13] - A-share companies are undergoing significant stock price fluctuations, with several companies like Pingtan Development and Haixia Innovation facing stock suspension for investigation due to abnormal price movements [14] - SMIC is experiencing a supply shortage in the memory industry, leading to sustained high prices [14]

Core Points - The fifth China-Korea Future Economic Cooperation Forum was held in Seoul on November 13, emphasizing the importance of bilateral relations and cooperation in various sectors [1][3][5] Group 1: Forum Overview - The forum was co-hosted by the Chinese Embassy in South Korea, Asia Daily, and Asia News Group, with over 60 attendees from both countries, including diplomats, business leaders, and scholars [3][5] - Chinese Ambassador to South Korea, Dai Bing, highlighted the successful state visit of President Xi Jinping to South Korea, which opened a new chapter in China-Korea relations [5] Group 2: Economic Cooperation - Bilateral trade between China and South Korea has exceeded 300 billion USD, indicating a deepening mutually beneficial relationship over 33 years of diplomatic ties [5] - The forum aimed to deepen mutual understanding and explore cooperation potential in emerging fields such as artificial intelligence, biomedicine, and green industries [5][7] Group 3: Industry Collaboration - Korean representatives emphasized the need for trust and win-win cooperation to address new challenges and opportunities arising from global supply chain restructuring and technological competition [7] - Discussions at the forum included topics such as new models of China-Korea technological cooperation, collaboration in AI and robotics, biomedicine and cosmetics industries, currency swaps, cross-border investment, and joint private equity fund construction [7]